Hui Shao
Director/Board Member en Hangzhou Adlai Nortye Biopharma Co. Ltd. .
Perfil
Hui Shao currently works at Hangzhou Adlai Nortye Biopharma Co. Ltd., as Non-Executive Director from 2020 and Adlai Nortye USA, Inc., as Director from 2020.
Mr. Shao also formerly worked at Adlai Nortye Ltd., as Non-Executive Director.
Mr. Shao received his undergraduate degree in 1993 from Northeast Normal University.
Cargos activos de Hui Shao
Empresas | Cargo | Inicio |
---|---|---|
Hangzhou Adlai Nortye Biopharma Co. Ltd.
Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The private company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Director/Board Member | 01/02/2020 |
Adlai Nortye USA, Inc. | Director/Board Member | 01/01/2020 |
Antiguos cargos conocidos de Hui Shao.
Empresas | Cargo | Fin |
---|---|---|
ADLAI NORTYE LTD. | Director/Board Member | - |
Formación de Hui Shao.
Northeast Normal University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ADLAI NORTYE LTD. | Commercial Services |
Empresas privadas | 2 |
---|---|
Hangzhou Adlai Nortye Biopharma Co. Ltd.
Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The private company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Health Technology |
Adlai Nortye USA, Inc. |
- Bolsa de valores
- Insiders
- Hui Shao